NVLX, Nuvilex's pancreatic cancer treatment uses the company's "Cell-in-a-Box" or living cell encapsulation technology along with the single anticancer drug ifosfamide. The encapsulated cells are capable of converting the ifosfamide into its cancer-killing form.
Market Data 
Markets 
AI
